source
- CVS Caremark settles FTC antitrust case, agreeing to favor lowest-cost insulin on formulariesCVS Caremark announced a settlement with the Federal Trade Commission that resolves the agency’s antitrust lawsuit alleging the PBM favored higher-priced insulin versions. Under the agreement, Car…
- Avere Therapeutics to go public via reverse merger, secures $320M to advance long-acting psoriasis pillAvere Therapeutics, a privately held immunology drug developer, announced a plan to become a public company through a reverse merger with NextCure. The transaction includes $320 million in new cap…